Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JBP Korea is the South Korean subsidiary of Japan Bio Products Co., Ltd., a global leader in placenta-based pharmaceutical research and manufacturing. The company is primarily recognized for its flagship product, Laennec, a human placenta extract used for treating chronic liver disease and enhancing regenerative health. Beyond pharmaceuticals, JBP Korea has established a strong presence in the aesthetic medicine market with its JBP Nanoneedle and JBP V-Line lifting threads. Their product portfolio also includes Curacen, a specialized placenta-derived biologic designed for dermatological and anti-aging applications. The company utilizes advanced molecular fractionation technology to ensure the safety and potency of its biological products. JBP Korea serves as a critical hub for the distribution and clinical support of JBP's technologies across the Asian aesthetic and medical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JBP Korea.